Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The carboxymethylenebutenolidase homolog pseudogene (LOC100132669; ENSG00000225304) is a non-protein-coding genetic sequence in humans homologous to the functional carboxymethylenebutenolidase (CMBL) enzyme gene. CMBL is a cysteine hydrolase of the dienelactone hydrolase family involved in the activation of certain drug prodrugs (such as olmesartan medoxomil, faropenem medoxomil, and lenampicillin). However, the pseudogene LOC100132669 does not encode any functional protein and thus does not contribute to these biological activities. All drug metabolism functions, disease associations, molecular activity, and related research refer to the protein-coding gene CMBL (e.g., ENSG00000164237), not the pseudogene LOC100132669. The pseudogene itself holds no therapeutic target status and is not relevant for drug interactions or biomarker development. If you seek information about the actionable therapeutic target, search for "Carboxymethylenebutenolidase homolog (CMBL)" rather than this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carboxymethylenebutenolidase homolog pseudogene (LOC100132669).